Dawn Lepore joined the Pershing Square Advisory Board in the quarter referred to as "this quarter" in the statement made on 2018-05-17.
Unresolvable The public record could not settle it.
Factual: Statements about the present or the past, checked against the record: did they hold up?
The evidence is the person's or their organisation's own records.
Said for an organisation they lead or work for; it counts on both records.
What would count as true or false
"This quarter" is read as the quarter covered by the 2018-05-17 communication (likely Q1 2018 if it is a quarterly letter, or Q2 2018 if it means the quarter then under way). True if Dawn Lepore was appointed to or joined the Pershing Square Advisory Board during that quarter, as shown by Pershing Square's reports, letters or announcements. Mostly true if she joined within the period from the start of Q1 2018 to 2018-05-17, but the exact quarter is ambiguous or slightly different. Mostly false if she joined the Advisory Board but in an earlier period, such as 2017. False if she did not join the Pershing Square Advisory Board at all.
Set before the research began.
Evidence (3)
-
E1 PSCM Annual Investor Update Presentation Pershing Square Capital Management, L.P. · 13 February 2019 Own record
“Added Dawn Lepore, former CEO and President of Drugstore.com Inc.”
-
E2 London Investor Meeting (Pershing Square Capital Management annual investor update presentation) Pershing Square Capital Management, L.P. · 13 February 2019 Own record
“Added Dawn Lepore, former CEO and President of Drugstore.com Inc.”
-
E3 Pershing Square Holdings Ltd. Releases 2018 Semiannual Financial Statements | Pershing Square Holdings Pershing Square Holdings, Ltd. · 9 August 2018 Own record
“members of the PSCM advisory board combined purchased more than $300 million of PSH Public Shares.”
Reasoning
E1 and E2 are slides from Pershing Square's February 2019 annual investor update. They list Dawn Lepore as added to the Advisory Board, which confirms she joined, but the quotes give no quarter or date for her appointment. E3 mentions purchases by advisory board members and says nothing about Lepore or when she joined. Nothing in the evidence places her joining in Q1 2018, in Q2 2018, or anywhere between the start of 2018 and 2018-05-17, so the timing in the claim cannot be confirmed.
Cite this claim
Bill Ackman, “Dawn Lepore joined the Pershing Square Advisory Board in the quarter referred to as "this quarter" in the statement made on 2018-05-17.” (said 17 May 2018). Verdict: unresolvable. Reliability API, claim c_06948750b297, method 0.1.0+c876030c, dataset release v1.1.2. https://epistacklabs.com/claims/c_06948750b297
This claim is in dataset release v1.1.2, with the same verdict.
Reply to this claim
More factual claims by Bill Ackman
-
Mixed
“You own a portfolio of our best ideas, and it’s trading at an 18% discount to cash.”
PSUS holds a portfolio of Pershing Square's best ideas and trades at an 18% discount to cash.
-
Mostly true
“This lower return reflects the 35% discount to NAV at which PSH's stock currently trades.”
-
Resolved true
“We recently made new investments in Visa (V), Mastercard (MA), Netflix, S&P Global, Intercontinental Exchange, and Alcon (ALC), companies we have closely followed for years.”
-
Resolved true
“Streetwise is now available for sale. Please see my review below.”
-
Mixed
“Our new independent directors include long-term investors in PSH and the Pershing Square funds as well as new investors in the management company.”
Verdicts are made automatically; how verdicts are made.